Evidence map›Paper›PMID 33807834›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Tzu-Jung Yu, Yuan-Bin Cheng, Li-Ching Lin, Yi-Hong Tsai, Bo-Yi Yao, Jen-Yang Tang, Fang-Rong Chang, Chia-Hung Yen, Fu Ou-Yang, Hsueh-Wei Chang

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Combinatorial chemistry & high throughput screening · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tzu-Jung YuGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Yuan-Bin ChengGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0001-6581-1320
Li-Ching LinDepartment of Radiation Oncology, Chi-Mei Foundation Medical Center, Tainan 71004, Taiwan.
Yi-Hong TsaiGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Bo-Yi YaoGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Jen-Yang TangSchool of Post-Baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-5690-0708
Fang-Rong ChangGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0003-2549-4193
Chia-Hung YenGraduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-6939-5528
Fu Ou-YangDivision of Breast Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Hsueh-Wei ChangCenter for Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0003-0068-2366
Kaohsiung Medical University · TWNational Sun Yat-sen University · TWChung Hwa University of Medical Technology · TW

Funding

Health and Welfare Surcharge of Tobacco Products, the Ministry of Health and Welfare, Taiwan MOHW 109-TDU-B-212-134016Kaohsiung Medical University Hospital KMUH109-9R35Kaohsiung Medical University Research Center KMU-TC108A04Ministry of Science and Technology, Taiwan MOST 108-2314-B-037-080Ministry of Science and Technology, Taiwan MOST 108-2320-B-037-015-MY3Ministry of Science and Technology, Taiwan MOST 109-2314-B-037-018Ministry of Science and Technology, Taiwan MOST 109-2628-B-110-004Ministry of Science and Technology, Taiwan MOST 109-2740-B-037-001National Sun Yat-sen University-Kaohsiung Medical University (KMU) Joint Research Project #NSYSUKMU 110-P016
6 · The paper itself

Abstract

Breast cancer expresses clinically heterogeneous characteristics and requires multipurpose drug development for curing the different tumor subtypes. Many withanolides have been isolated from

Indexed as

apoptosisbreast cancerDNA damageoxidative stresswithanolide

Identifiers

PMID33807834
PMCPMC7998541
OpenAlexW3135805340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.